SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-010727
Filing Date
2017-11-02
Accepted
2017-11-02 17:23:56
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3 2017 ARBUTUS BIOPHARMA arbutusq32017.htm 10-Q 896271
2 EXHIBIT 10.1 SUBSCRIPTION AGREEMENT exhibit101q32017.htm EX-10.1 744005
3 EXHIBIT 31.1 exhibit311q32017.htm EX-31.1 13496
4 EXHIBIT 31.2 exhibit312q32017.htm EX-31.2 13968
5 EXHIBIT 32.1 exhibit321q32017.htm EX-32.1 6607
6 EXHIBIT 32.2 exhibit322q32017.htm EX-32.2 6938
13 pipeline2017a01.jpg GRAPHIC 43968
  Complete submission text file 0001628280-17-010727.txt   4399545

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abus-20170930.xml EX-101.INS 586287
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20170930.xsd EX-101.SCH 34631
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20170930_cal.xml EX-101.CAL 56524
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20170930_def.xml EX-101.DEF 119362
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20170930_lab.xml EX-101.LAB 392568
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20170930_pre.xml EX-101.PRE 201774
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 171173761
SIC: 2834 Pharmaceutical Preparations